{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T23:41:01Z","timestamp":1792885261501,"version":"4.5.0"},"reference-count":116,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2005,6,1]],"date-time":"2005-06-01T00:00:00Z","timestamp":1117584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,6,1]],"date-time":"2005-06-01T00:00:00Z","timestamp":1117584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2005,6]]},"DOI":"10.1016\/j.amjmed.2005.01.001","type":"journal-article","created":{"date-parts":[[2005,5,27]],"date-time":"2005-05-27T11:01:28Z","timestamp":1117191688000},"page":"592-603","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":105,"title":["Spondyloarthritis: update on pathogenesis and management"],"prefix":"10.1016","volume":"118","author":[{"given":"John D.","family":"Reveille","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank C.","family":"Arnett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjmed.2005.01.001_bib1","series-title":"ACP Medicine, 2004\u20132005","first-page":"1350","article-title":"Seronegative spondyloarthropathies","author":"Arnett","year":"2004"},{"key":"10.1016\/j.amjmed.2005.01.001_bib2","series-title":"Kelley\u2019s Textbook of Rheumatology","first-page":"1039","article-title":"Spondylarthopathies","author":"van der Linden","year":"2000"},{"key":"10.1016\/j.amjmed.2005.01.001_bib3","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/00002281-200207000-00001","article-title":"Anterior uveitis","volume":"14","author":"Martin","year":"2002","journal-title":"Curr Opin Rheumatol."},{"key":"10.1016\/j.amjmed.2005.01.001_bib4","doi-asserted-by":"crossref","first-page":"621","DOI":"10.7326\/0003-4819-127-8_Part_1-199710150-00007","article-title":"HLA-B27-associated cardiac disease","volume":"127","author":"Bergfeldt","year":"1997","journal-title":"Ann Intern Med."},{"key":"10.1016\/j.amjmed.2005.01.001_bib5","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1136\/ard.59.11.883","article-title":"Recurrence risk modelling of the genetic susceptibility to ankylosing spondylitis","volume":"59","author":"Brown","year":"2000","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.amjmed.2005.01.001_bib6","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1002\/art.1780401015","article-title":"Susceptibility to ankylosing spondylitis in twins","volume":"40","author":"Brown","year":"1997","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.amjmed.2005.01.001_bib7","doi-asserted-by":"crossref","first-page":"5543","DOI":"10.4049\/jimmunol.167.10.5543","article-title":"Leukocyte receptor complex-encoded immunomodulatory receptors show differing specificity for alternative HLA-B27 structures","volume":"167","author":"Allen","year":"2001","journal-title":"J Immunol."},{"issue":"6 Suppl 28","key":"10.1016\/j.amjmed.2005.01.001_bib8","first-page":"S43","article-title":"Genetics of ankylosing spondylitis","volume":"20","author":"Brown","year":"2002","journal-title":"Clin Exp Rheumatol."},{"key":"10.1016\/j.amjmed.2005.01.001_bib9","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1002\/1529-0131(200007)43:7<1527::AID-ANR17>3.0.CO;2-G","article-title":"Modification of disease outcome in Salmonella-infected patients by HLA-B27","volume":"43","author":"Ekman","year":"2000","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.amjmed.2005.01.001_bib10","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/00002281-200107000-00004","article-title":"HLA-B27 and genetic predisposing factors in spondyloarthropathies","volume":"13","author":"Reveille","year":"2001","journal-title":"Curr Opin Rheumatol."},{"key":"10.1016\/j.amjmed.2005.01.001_bib11","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S1521-6942(03)00003-2","article-title":"Articular manifestations of human immunodeficiency virus infection","volume":"17","author":"Mody","year":"2003","journal-title":"Best Pract Res Clin Rheumatol."},{"key":"10.1016\/j.amjmed.2005.01.001_bib12","doi-asserted-by":"crossref","first-page":"5778","DOI":"10.4049\/jimmunol.170.11.5778","article-title":"Allospecific T cell epitope sharing reveals extensive conservation of the antigenic features of peptide ligands among HLA-B27 subtypes differentially associated with spondyloarthritis","volume":"170","author":"Montserrat","year":"2003","journal-title":"J Immunol."},{"key":"10.1016\/j.amjmed.2005.01.001_bib13","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1074\/jbc.M307457200","article-title":"Thermodynamic and structural analysis of peptide- and allele-dependent properties of two HLA-B27 subtypes exhibiting differential disease association","volume":"279","author":"Hillig","year":"2004","journal-title":"J Biol Chem."},{"key":"10.1016\/j.amjmed.2005.01.001_bib14","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1084\/jem.20031690","article-title":"Dual, HLA-B27 subtype-dependent conformation of a self-peptide","volume":"199","author":"Hulsmeyer","year":"2004","journal-title":"J Exp Med."},{"key":"10.1016\/j.amjmed.2005.01.001_bib15","doi-asserted-by":"crossref","first-page":"23459","DOI":"10.1074\/jbc.M110336200","article-title":"HLA-B27 misfolding is associated with aberrant intermolecular disulfide bond formation (dimerization) in the endoplasmic reticulum","volume":"277","author":"Dangoria","year":"2002","journal-title":"J Biol Chem."},{"key":"10.1016\/j.amjmed.2005.01.001_bib16","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1002\/eji.200323678","article-title":"Lymphoblastoid cells express HLA-B27 homodimers both intracellularly and at the cell surface following endosomal recycling","volume":"33","author":"Bird","year":"2003","journal-title":"Eur J Immunol."},{"key":"10.1016\/j.amjmed.2005.01.001_bib17","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.1002\/art.10605","article-title":"Cell-surface expression and immune receptor recognition of HLA-B27 homodimers","volume":"46","author":"Kollnberger","year":"2002","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.amjmed.2005.01.001_bib18","doi-asserted-by":"crossref","first-page":"4738","DOI":"10.4049\/jimmunol.167.8.4738","article-title":"Identification of HLA-B27-restricted peptides from the Chlamydia trachomatis proteome with possible relevance to HLA-B27-associated diseases","volume":"167","author":"Kuon","year":"2001","journal-title":"J Immunol."},{"key":"10.1016\/j.amjmed.2005.01.001_bib19","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1172\/JCI9295","article-title":"CD8(+) T-cell autoreactivity to an HLA-B27-restricted self-epitope correlates with ankylosing spondylitis","volume":"106","author":"Fiorillo","year":"2000","journal-title":"J Clin Invest."},{"key":"10.1016\/j.amjmed.2005.01.001_bib20","doi-asserted-by":"crossref","first-page":"3830","DOI":"10.4049\/jimmunol.162.7.3830","article-title":"Common intra-articular T cell expansions in patients with reactive arthritis","volume":"162","author":"Dulphy","year":"1999","journal-title":"J Immunol."},{"key":"10.1016\/j.amjmed.2005.01.001_bib21","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1128\/IAI.70.3.1609-1614.2002","article-title":"HLA-B27-transfected (Salmonella permissive) and HLA-A2-transfected (Salmonella nonpermissive) human monocytic U937 cells differ in their production of cytokines","volume":"70","author":"Ekman","year":"2002","journal-title":"Infect Immun."},{"key":"10.1016\/j.amjmed.2005.01.001_bib22","first-page":"1291","article-title":"Determinants of synoviocyte clearance of arthritogenic bacteria","volume":"30","author":"Inman","year":"2003","journal-title":"J Rheumatol."},{"key":"10.1016\/j.amjmed.2005.01.001_bib23","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.4049\/jimmunol.167.5.2619","article-title":"The recognition of HLA-B27 by human CD4(+) T lymphocytes","volume":"167","author":"Boyle","year":"2001","journal-title":"J Immunol."},{"key":"10.1016\/j.amjmed.2005.01.001_bib24","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/art.1780270301","article-title":"The risk of developing ankylosing spondylitis in HLA-B27 positive individuals. A comparison of relatives of spondylitis patients with the general population","volume":"27","author":"van der Linden","year":"1984","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.amjmed.2005.01.001_bib25","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1002\/1529-0131(199803)41:3<460::AID-ART12>3.0.CO;2-X","article-title":"The effect of HLA-DR genes on susceptibility to and severity of ankylosing spondylitis","volume":"41","author":"Brown","year":"1998","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.amjmed.2005.01.001_bib26","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1136\/ard.61.3.201","article-title":"The role of HLA genes in familial spondyloarthropathy","volume":"61","author":"Said-Nahal","year":"2002","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.amjmed.2005.01.001_bib27","first-page":"451","article-title":"Microsatellite polymorphism of the MICA gene and susceptibility to rheumatoid arthritis","volume":"19","author":"Singal","year":"2001","journal-title":"Clin Exp Rheumatol."},{"key":"10.1016\/j.amjmed.2005.01.001_bib28","first-page":"1288","article-title":"TNF-238A promoter polymorphism contributes to susceptibility to ankylosing spondylitis in HLA-B27 negative patients","volume":"28","author":"Gonzalez","year":"2001","journal-title":"J Rheumatol."},{"key":"10.1016\/j.amjmed.2005.01.001_bib29","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1002\/1529-0131(199808)41:8<1489::AID-ART20>3.0.CO;2-5","article-title":"Association of different tumor necrosis factor alpha promoter allele frequencies with ankylosing spondylitis in HLA-B27 positive individuals","volume":"41","author":"Hohler","year":"1998","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.amjmed.2005.01.001_bib30","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1136\/ard.61.1.48","article-title":"Heat shock protein 70 gene polymorphisms in Mexican patients with spondyloarthropathies","volume":"61","author":"Vargas-Alarcon","year":"2002","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.amjmed.2005.01.001_bib31","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1159\/000019139","article-title":"TAP1 and TAP2 polymorphism in Spanish patients with ankylosing spondylitis","volume":"17","author":"Fraile","year":"2000","journal-title":"Exp Clin Immunogene."},{"key":"10.1016\/j.amjmed.2005.01.001_bib32","first-page":"183","article-title":"LMP2 polymorphism is associated with extraspinal disease in HLA-B27 negative Caucasian and Mexican Mestizo patients with ankylosing spondylitis","volume":"27","author":"Maksymowych","year":"2000","journal-title":"J Rheumatol."},{"key":"10.1016\/j.amjmed.2005.01.001_bib33","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1172\/JCI109903","article-title":"Histocompatibility alloantigens in psoriasis and psoriatic arthritis. Evidence for the influence of multiple genes in the major histocompatibility complex","volume":"66","author":"Murray","year":"1980","journal-title":"J Clin Invest."},{"key":"10.1016\/j.amjmed.2005.01.001_bib34","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S0016-5085(00)70209-5","article-title":"Clinical phenotype is related to HLA genotype in the peripheral arthropathies of inflammatory bowel disease","volume":"118","author":"Orchard","year":"2000","journal-title":"Gastroenterology."},{"key":"10.1016\/j.amjmed.2005.01.001_bib35","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1086\/319509","article-title":"Whole-genome screening in ankylosing spondylitis","volume":"68","author":"Laval","year":"2001","journal-title":"Am J Hum Genet."},{"key":"10.1016\/j.amjmed.2005.01.001_bib36","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/art.1780380414","article-title":"HLA-DR8 and acute anterior uveitis in ankylosing spondylitis","volume":"38","author":"Monowarul Islam","year":"1995","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.amjmed.2005.01.001_bib37","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1002\/art.20308","article-title":"Genetic studies in familial ankylosing spondylitis susceptibility","volume":"50","author":"Zhang","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.amjmed.2005.01.001_bib38","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1093\/hmg\/ddh179","article-title":"Significant linkage to spondyloarthropathy on 9q31\u201334","volume":"13","author":"Miceli-Richard","year":"2004","journal-title":"Hum Mol Genet."},{"key":"10.1016\/j.amjmed.2005.01.001_bib39","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1086\/302932","article-title":"Localization of psoriasis-susceptibility locus PSORS1 to a 60-kb interval telomeric to HLA-C","volume":"66","author":"Nair","year":"2000","journal-title":"Am J Hum Genet."},{"key":"10.1016\/j.amjmed.2005.01.001_bib40","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1126\/science.8178173","article-title":"Gene for familial psoriasis susceptibility mapped to the distal end of human chromosome 17q","volume":"264","author":"Tomfohrde","year":"1994","journal-title":"Science."},{"key":"10.1016\/j.amjmed.2005.01.001_bib41","doi-asserted-by":"crossref","first-page":"9979","DOI":"10.1073\/pnas.95.17.9979","article-title":"Clustering of non-major histocompatibility complex susceptibility candidate loci in human autoimmune diseases","volume":"95","author":"Becker","year":"1998","journal-title":"Proc Natl Acad Sci (USA)."},{"key":"10.1016\/j.amjmed.2005.01.001_bib42","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1086\/378076","article-title":"CARD15","volume":"73","author":"Rahman","year":"2003","journal-title":"Am J Hum Genet."},{"key":"10.1016\/j.amjmed.2005.01.001_bib43","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1038\/379821a0","article-title":"Mapping of a susceptibility locus for Crohn\u2019s disease on chromosome 16","volume":"379","author":"Hugot","year":"1996","journal-title":"Nature (London)."},{"key":"10.1016\/j.amjmed.2005.01.001_bib44","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1053\/gast.2003.50045","article-title":"The genetics of inflammatory bowel disease","volume":"124","author":"Bonen","year":"2003","journal-title":"Gastroenterology."},{"key":"10.1016\/j.amjmed.2005.01.001_bib45","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1002\/art.10329","article-title":"Role of NOD2 variants in spondylarthritis","volume":"46","author":"Crane","year":"2002","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.amjmed.2005.01.001_bib46","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1002\/art.10196","article-title":"CARD15\/NOD2 analyses in spondylarthropathy","volume":"46","author":"Miceli-Richard","year":"2002","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.amjmed.2005.01.001_bib47","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1136\/ard.55.1.66","article-title":"Relationship between genotype for the cytochrome P450 CYP2D6 and susceptibility to ankylosing spondylitis and rheumatoid arthritis","volume":"55","author":"Beyeler","year":"1996","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.amjmed.2005.01.001_bib48","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1093\/hmg\/9.11.1563","article-title":"Polymorphisms of the CYP2D6 gene increase susceptibility to ankylosing spondylitis","volume":"9","author":"Brown","year":"2000","journal-title":"Hum Mol Genet."},{"key":"10.1016\/j.amjmed.2005.01.001_bib49","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1086\/424695","article-title":"The interleukin 1 gene cluster contains a major susceptibility locus for ankylosing spondylitis","volume":"75","author":"Timms","year":"2004","journal-title":"Am J Hum Genet."},{"key":"10.1016\/j.amjmed.2005.01.001_bib50","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1093\/rheumatology\/40.12.1359","article-title":"A polymorphism within the interleukin 1 receptor antagonist (IL-1Ra) gene is associated with ankylosing spondylitis","volume":"40","author":"McGarry","year":"2001","journal-title":"Rheumatology (Oxford)."},{"key":"10.1016\/j.amjmed.2005.01.001_bib51","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1093\/rheumatology\/41.12.1419","article-title":"Interleukin-1beta and interleukin-1 receptor antagonist gene polymorphisms in ankylosing spondylitis","volume":"41","author":"van der Paardt","year":"2002","journal-title":"Rheumatology (Oxford)."},{"key":"10.1016\/j.amjmed.2005.01.001_bib52","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1002\/art.11037","article-title":"High throughput single nucleotide polymorphism (SNP) analysis of the interleukin-1 receptor antagonist (IL-1 RN) locus in patients with ankylosing spondylitis (AS) by MALDI-TOF mass spectroscopy","volume":"48","author":"Maksymowych","year":"2003","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.amjmed.2005.01.001_bib53","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1002\/art.20475","article-title":"Lack of linkage of IL1RN genotypes with ankylosing spondylitis susceptibility","volume":"50","author":"Jin","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.amjmed.2005.01.001_bib54","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/art.10844","article-title":"Novel genetic markers in the 5\u2019-flanking region of ANKH are associated with ankylosing spondylitis","volume":"48","author":"Tsui","year":"2003","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.amjmed.2005.01.001_bib55","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1002\/art.11258","article-title":"Investigation of the role of ANKH in ankylosing spondylitis","volume":"48","author":"Timms","year":"2003","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.amjmed.2005.01.001_bib56","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1093\/rheumatology\/39.5.530","article-title":"Polymorphic CAG repeats of the androgen receptor gene in Japanese male patients with ankylosing spondylitis","volume":"39","author":"Mori","year":"2000","journal-title":"Rheumatology (Oxford)."},{"key":"10.1016\/j.amjmed.2005.01.001_bib57","first-page":"1461","article-title":"Interleukin 6 gene promoter polymorphism is not associated with ankylosing spondylitis","volume":"27","author":"Collado-Escobar","year":"2000","journal-title":"J Rheumatol."},{"key":"10.1016\/j.amjmed.2005.01.001_bib58","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/sj.gene.6363930","article-title":"Interleukin 10 polymorphisms in ankylosing spondylitis","volume":"4","author":"Goedecke","year":"2003","journal-title":"Genes Immun."},{"key":"10.1016\/j.amjmed.2005.01.001_bib59","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1093\/rheumatology\/keh426","article-title":"Transforming growth factor beta-1 and gene polymorphisms in oriental ankylosing spondylitis","volume":"44","author":"Howe","year":"2005","journal-title":"Rheumatology (Oxford)."},{"key":"10.1016\/j.amjmed.2005.01.001_bib60","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1002\/art.10935","article-title":"Cytokine gene polymorphisms","volume":"48","author":"Balding","year":"2003","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.amjmed.2005.01.001_bib61","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1002\/art.11106","article-title":"Identification of major loci controlling clinical manifestations of ankylosing spondylitis","volume":"48","author":"Brown","year":"2003","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.amjmed.2005.01.001_bib62","doi-asserted-by":"crossref","first-page":"896","DOI":"10.7326\/0003-4819-136-12-200206180-00011","article-title":"Update on spondyloarthropathies","volume":"136","author":"Khan","year":"2002","journal-title":"Ann Intern Med."},{"key":"10.1016\/j.amjmed.2005.01.001_bib63","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/1529-0131(199901)42:1<84::AID-ANR11>3.0.CO;2-C","article-title":"Salmonella-triggered reactive arthritis","volume":"42","author":"Nikkari","year":"1999","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.amjmed.2005.01.001_bib64","first-page":"734","article-title":"Synovial chlamydia trachomatis in patients with reactive arthritis\/Reiter\u2019s syndrome are viable but show aberrant gene expression","volume":"25","author":"Gerard","year":"1998","journal-title":"J Rheumatol."},{"key":"10.1016\/j.amjmed.2005.01.001_bib65","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1002\/1529-0131(199906)42:6<1281::AID-ANR27>3.0.CO;2-8","article-title":"Chlamydia trachomatis nucleic acids can be found in the synovium of some asymptomatic subjects","volume":"42","author":"Schumacher","year":"1999","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.amjmed.2005.01.001_bib66","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1136\/ard.39.6.545","article-title":"Association of inflammation with raised serum IgA in ankylosing spondylitis","volume":"39","author":"Cowling","year":"1980","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.amjmed.2005.01.001_bib67","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1093\/rheumatology\/keg482","article-title":"Comparative immune responses to candidate arthritogenic bacteria do not confirm a dominant role for Klebsiella pneumonia in the pathogenesis of familial ankylosing spondylitis","volume":"43","author":"Stone","year":"2004","journal-title":"Rheumatology (Oxford)."},{"key":"10.1016\/j.amjmed.2005.01.001_bib68","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1093\/rheumatology\/41.12.1395","article-title":"Comparison of the faecal microflora of patients with ankylosing spondylitis and controls using molecular methods of analysis","volume":"41","author":"Stebbings","year":"2002","journal-title":"Rheumatology (Oxford)."},{"key":"10.1016\/j.amjmed.2005.01.001_bib69","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/j.1525-1470.2003.20611.x","article-title":"Childhood pustular psoriasis elicited by the streptococcal antigen","volume":"20","author":"Cassandra","year":"2003","journal-title":"Pediatr Dermatol."},{"key":"10.1016\/j.amjmed.2005.01.001_bib70","first-page":"1542","article-title":"Gut inflammation in the spondyloarthropathies: clinical, radiologic, biologic and genetic features in relation to the type of histology: a prospective study","volume":"18","author":"Mielants","year":"1991","journal-title":"J Rheumatol."},{"key":"10.1016\/j.amjmed.2005.01.001_bib71","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/art.1780370105","article-title":"High frequency of silent inflammatory bowel disease in spondylarthropathy","volume":"37","author":"Leirisalo-Repo","year":"1994","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.amjmed.2005.01.001_bib72","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1093\/rheumatology\/33.7.644","article-title":"Intestinal permeability in patients with ankylosing spondylitis and their healthy relatives","volume":"33","author":"Martinez-Gonzalez","year":"1994","journal-title":"Br J Rheumatol."},{"key":"10.1016\/j.amjmed.2005.01.001_bib73","first-page":"2225","article-title":"Preliminary core sets for endpoints in ankylosing spondylitis","volume":"24","author":"van der Heijde","year":"1997","journal-title":"J Rheumatol."},{"key":"10.1016\/j.amjmed.2005.01.001_bib74","first-page":"2286","article-title":"A new approach to defining disease status in ankylosing spondylitis. The Bath ankylosing spondylitis disease activity index","volume":"21","author":"Garrett","year":"1994","journal-title":"J Rheumatol."},{"key":"10.1016\/j.amjmed.2005.01.001_bib75","first-page":"2281","article-title":"A new approach to defining functional ability in ankylosing spondylitis. The Bath ankylosing spondylitis functional index","volume":"21","author":"Calin","year":"1994","journal-title":"J Rheumatol."},{"key":"10.1016\/j.amjmed.2005.01.001_bib76","first-page":"946","article-title":"A modification of the Health Assessment Questionnaire for the spondyloarthropathies","volume":"17","author":"Daltroy","year":"1990","journal-title":"J Rheumatol."},{"key":"10.1016\/j.amjmed.2005.01.001_bib77","first-page":"1694","article-title":"Defining spinal mobility in ankylosing spondylitis (AS). The Bath AS Metrology Index","volume":"21","author":"Jenkinson","year":"1994","journal-title":"J Rheumatol."},{"key":"10.1016\/j.amjmed.2005.01.001_bib78","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection","volume":"30","author":"Ware","year":"1992","journal-title":"Med Care."},{"key":"10.1016\/j.amjmed.2005.01.001_bib79","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1093\/rheumatology\/41.11.1295","article-title":"Disease-specific, patient-assessed measures of health outcome in ankylosing spondylitis","volume":"41","author":"Haywood","year":"2002","journal-title":"Rheumatology (Oxford)."},{"key":"10.1016\/j.amjmed.2005.01.001_bib80","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1002\/1529-0131(199812)41:12<2263::AID-ART23>3.0.CO;2-I","article-title":"The Bath ankylosing spondylitis radiology index (BASRI)","volume":"41","author":"MacKay","year":"1998","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.amjmed.2005.01.001_bib81","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1002\/art.20446","article-title":"What is the most appropriate radiologic scoring method for ankylosing spondylitis? A comparison of the available methods based on the Outcome Measures in Rheumatology Clinical Trials filter","volume":"50","author":"Wanders","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.amjmed.2005.01.001_bib82","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1002\/art.10883","article-title":"Improvement of spinal inflammation in ankylosing spondylitis (AS) by infliximab therapy as assessed by magnetic resonance imaging (MRI) using a novel evaluated spinal scoring system","volume":"48","author":"Braun","year":"2003","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.amjmed.2005.01.001_bib83","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1001\/archinte.160.19.2969","article-title":"Exercise and changes in health status in patients with ankylosing spondylitis","volume":"160","author":"Uhrin","year":"2000","journal-title":"Arch Intern Med."},{"key":"10.1016\/j.amjmed.2005.01.001_bib84","article-title":"Physiotherapy interventions for ankylosing spondylitis","author":"Dagfinrud","year":"2001","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.amjmed.2005.01.001_bib85","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/art.1780380507","article-title":"Sulfasalazine in the treatment of spondylarthropathy","volume":"38","author":"Dougados","year":"1995","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.amjmed.2005.01.001_bib86","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1002\/1529-0131(199911)42:11<2325::AID-ANR10>3.0.CO;2-C","article-title":"Comparison of sulfasalazine and placebo for the treatment of axial and peripheral articular manifestations of the seronegative spondylarthropathies","volume":"42","author":"Clegg","year":"1999","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.amjmed.2005.01.001_bib87","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1002\/art.1780390819","article-title":"Which is the active moiety of sulfasalazine in ankylosing spondylitis? A randomized controlled study","volume":"39","author":"Taggart","year":"1996","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.amjmed.2005.01.001_bib88","first-page":"1104","article-title":"Methotrexate in severe ankylosing spondylitis","volume":"22","author":"Creemers","year":"1995","journal-title":"J Rheumatol."},{"key":"10.1016\/j.amjmed.2005.01.001_bib89","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1080\/030097401753180318","article-title":"Clinical investigation of methotrexate in the treatment of ankylosing spondylitis","volume":"30","author":"Altan","year":"2001","journal-title":"Scand J Rheumatol."},{"key":"10.1016\/j.amjmed.2005.01.001_bib90","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1093\/rheumatology\/35.8.767","article-title":"Assessment of the efficacy of sacroiliac corticosteroid injections in spondylarthropathies","volume":"35","author":"Maugars","year":"1996","journal-title":"Br J Rheumatol."},{"key":"10.1016\/j.amjmed.2005.01.001_bib91","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/art.1780340103","article-title":"Double-blind, placebo-controlled study of three-month treatment with lymecycline in reactive arthritis, with special reference to chlamydia arthritis","volume":"34","author":"Lauhio","year":"1991","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.amjmed.2005.01.001_bib92","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1136\/ard.62.7.655","article-title":"Antibiotic treatment and long term prognosis of reactive arthritis","volume":"62","author":"Laasila","year":"2003","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.amjmed.2005.01.001_bib93","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1136\/ard.62.9.880","article-title":"Effect of a three month course of ciprofloxacin on the late prognosis of reactive arthritis","volume":"62","author":"Yli-Kerttula","year":"2003","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.amjmed.2005.01.001_bib94","first-page":"144","article-title":"Clinical and radiological amelioration of refractory peripheral spondyloarthritis by pulse intravenous pamidronate therapy","volume":"28","author":"Maksymowych","year":"2001","journal-title":"J Rheumatol."},{"key":"10.1016\/j.amjmed.2005.01.001_bib95","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/art.10396","article-title":"One-year open-label trial of thalidomide in ankylosing spondylitis","volume":"47","author":"Huang","year":"2002","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.amjmed.2005.01.001_bib96","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1002\/1529-0131(200006)43:6<1346::AID-ANR18>3.0.CO;2-E","article-title":"Successful treatment of active ankylosing spondylitis with the anti-tumor necrosis factor alpha monoclonal antibody infliximab","volume":"43","author":"Brandt","year":"2000","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.amjmed.2005.01.001_bib97","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1136\/ard.2004.025130","article-title":"Two-year maintenance of efficacy and safety of infliximab in the treatment of ankylosing spondylitis","volume":"64","author":"Braun","year":"2005","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.amjmed.2005.01.001_bib98","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1002\/art.10876","article-title":"Antinuclear antibodies following infliximab treatment in patients with rheumatoid arthritis or spondylarthropathy","volume":"48","author":"De Rycke","year":"2003","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.amjmed.2005.01.001_bib99","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJMoa012664","article-title":"Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor \u03b1","volume":"346","author":"Gorman","year":"2002","journal-title":"N Engl J Med."},{"key":"10.1016\/j.amjmed.2005.01.001_bib100","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/art.20241","article-title":"Results from an open-label extension study of etanercept in ankylosing spondylitis","volume":"51","author":"Davis","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.amjmed.2005.01.001_bib101","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1002\/1529-0131(200109)44:9<2112::AID-ART363>3.0.CO;2-H","article-title":"Efficacy of etanercept in the treatment of the entheseal pathology in resistant spondylarthropathy","volume":"44","author":"Marzo-Ortega","year":"2001","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.amjmed.2005.01.001_bib102","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0140-6736(00)02530-7","article-title":"Etanercept in the treatment of psoriatic arthritis and psoriasis","volume":"356","author":"Mease","year":"2000","journal-title":"Lancet."},{"key":"10.1016\/j.amjmed.2005.01.001_bib103","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/1529-0131(200106)45:3<252::AID-ART257>3.0.CO;2-5","article-title":"Differential efficacy of tumor necrosis factor inhibition in the management of inflammatory eye disease and associated rheumatic disease","volume":"45","author":"Smith","year":"2001","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.amjmed.2005.01.001_bib104","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1136\/ard.62.9.817","article-title":"International ASAS consensus statement for the use of anti-tumour necrosis factor agents in patients with ankylosing spondylitis","volume":"62","author":"Braun","year":"2003","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.amjmed.2005.01.001_bib105","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1007\/s00198-003-1501-5","article-title":"Vitamin D receptor initiation codon polymorphism, bone density and inflammatory activity of patients with ankylosing spondylitis","volume":"14","author":"Obermayer-Pietsch","year":"2003","journal-title":"Osteoporos Int."},{"key":"10.1016\/j.amjmed.2005.01.001_bib106","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s001980170084","article-title":"Changes in bone density in patients with ankylosing spondylitis","volume":"12","author":"Maillefert","year":"2001","journal-title":"Osteoporos Int."},{"key":"10.1016\/j.amjmed.2005.01.001_bib107","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1007\/s001980170013","article-title":"Relationship between disease activity and serum levels of vitamin D metabolites and parathyroid hormone in ankylosing spondylitis","volume":"12","author":"Lange","year":"2001","journal-title":"Osteoporos Int."},{"issue":"6 Suppl 28","key":"10.1016\/j.amjmed.2005.01.001_bib108","first-page":"S185","article-title":"Infliximab in spondylarthropathy-influence on bone density","volume":"20","author":"Demis","year":"2002","journal-title":"Clin Exp Rheumatol."},{"key":"10.1016\/j.amjmed.2005.01.001_bib109","first-page":"1862","article-title":"Total hip arthroplasty in ankylosing spondylitis","volume":"28","author":"Sweeney","year":"2001","journal-title":"J Rheumatol."},{"key":"10.1016\/j.amjmed.2005.01.001_bib110","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/S0883-5403(96)80180-X","article-title":"Primary noncemented total hip arthroplasty in patients with ankylosing spondylitis","volume":"11","author":"Brinker","year":"1996","journal-title":"J Arthroplasty."},{"key":"10.1016\/j.amjmed.2005.01.001_bib111","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1093\/rheumatology\/39.1.85","article-title":"The prevalence of vertebral fractures in mild ankylosing spondylitis and their relationship to bone mineral density","volume":"39","author":"Mitra","year":"2000","journal-title":"Rheumatology (Oxford)."},{"key":"10.1016\/j.amjmed.2005.01.001_bib112","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1136\/ard.58.7.399","article-title":"Lumbar osteotomy for correction of thoracolumbar kyphotic deformity in ankylosing spondylitis","volume":"58","author":"Van Royen","year":"1999","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.amjmed.2005.01.001_bib113","first-page":"2732","article-title":"Ceiling effects and the Schober test","volume":"30","author":"Ward","year":"2003","journal-title":"J Rheumatol."},{"key":"10.1016\/j.amjmed.2005.01.001_bib114","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s10067-003-0850-y","article-title":"Respiratory muscle strength but not BASFI score relates to diminished chest expansion in ankylosing spondylitis","volume":"23","author":"Sahin","year":"2004","journal-title":"Clin Rheumatol."},{"key":"10.1016\/j.amjmed.2005.01.001_bib115","first-page":"1779","article-title":"Measurement of spinal mobility in ankylosing spondylitis","volume":"31","author":"Heuft-Dorenbosch","year":"2004","journal-title":"J Rheumatol."},{"key":"10.1016\/j.amjmed.2005.01.001_bib116","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1021\/bi00328a025","article-title":"Primary structure of papain-solubilized human histocompatibility antigen HLA-B27","volume":"254","author":"Ezquerra","year":"1985","journal-title":"Biochemistry."}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934305000021?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934305000021?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T08:38:41Z","timestamp":1757579921000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002934305000021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6]]},"references-count":116,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2005,6]]}},"alternative-id":["S0002934305000021"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2005.01.001","relation":{},"ISSN":["0002-9343"],"issn-type":[{"value":"0002-9343","type":"print"}],"subject":[],"published":{"date-parts":[[2005,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Spondyloarthritis: update on pathogenesis and management","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2005.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}